µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º ?Q0I'RC
:>+\17tx
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ D`[Khs f
s@8w-]"
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) ",yc0 2<
/mA,F;
1. ICAM-1 Cr C=A=e
Qkcjr]#^$
2. interleukin 12(IL-12) 6gH{R$7L=
`d\r;cE%lm
3. tumor infiltrating lymphocyte c!#:E`
oD9^ID+
4. TCR/CD3 complex H[
m<RaG8
0[Ht_qxb
5. hematopoietin receptor family 424(3-/v;
:Dt~
e|
6. individual idiotype(IdI) Fv74bC%
as*4UT3
7. integrin 8CbXMT
\C,p
WW
8. colony-stimulatory factor (CSF) \xv;sl$f
1)m@?CaI`
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© !|ak^GE:(%
9h&R]yz;
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? #>lG7Ns|4
JN+_|`
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ 0k)rc$eDF+
5GA C`}}
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ#7ohQrP
ljTBvU
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ 86]p#n_>Fv
CI353-`
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) .L'.c/ s
Ym3\pRFiD
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ 0lhVqy}:}o
*98$dQR$
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) phM>.y_
5[c^TJ3
3. immunoglobulin superfamily (IgSF) +v=C@2T
d_IAs
4. selectin &Z`#cMR{H
#O+),,WS
5. anti-idiotypic antibody (¦ÁId) =Xo
=Qcr
J+`VujWT
6. major histocompatibility complex(MHC) N;\'N
ne
uD^cxD
7. immunotolerance G K7![p
V,%=AR5
8. biological reponse modifier(BRM)
5~>z h
8uWa=C)
9. immune reponse gene (Ir gene) 'IwNTM
dw*_(ys
10. reshaped antibody (or reconstituted antibody) INJEsz
iv4H#rJ
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Eea*s'
v_DedVhe
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ hpD!2 K3>
* -8&[D0
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? >&}%+r\
ivN&HAxI@
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ :g Wu9Y|{
4bYK}o
S
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? KV0]m^@x
xD~5UER
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ 62ws/8d6f
+[\FD; >
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? ]QlwR'&j/n
wNpTM8rfU#
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 1cpiHZa
T?ZRiR)@
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ z`f(
$t[
EVsC >rz
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? #Y
a4ps_
$QN"wL||
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ H4&lb}
|EX(8y
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: |B.Y6L6l
<7/R,\Wg~
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: O;:mCt _H
MOQ*]fV:
̉񧄤 mwHB(7YS,
S2sQOM@
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© n|9-KTe7|*
5\:^y'g[
1. CD8 cUKE
3no%E03p
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) RzE_K'M
G|!Tj X7s
3. immunoglobulin fold(Ig fold) }YGV\Nu
^c"jH'#.L
4. cadherin (Ca-dependent cell adhesion moleculers) %*A0# F
Cjm`|~&e+
5. idiotype-anti-idiotypic antibody immune network theory LDgrR[
UZ\u;/}
6. HLA class II antigen _|kxY'_[8
p& y<I6a,
7. complementarity-determining region (CDR) 81? hY4
{f3YsM;]C
8. perforin(or pore-forming protein ,PFP) XixL R
q;T{|5/O
9. high affinity IL-2 receptor _mqL8ho
-`*a'p-=
10. artificial active immunization O,{6*[)@
SoW9p^HJ
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© W9 GxXPA
XRM_x:+]
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠF~R;n_IJ
#++lg{
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 M8kPj8}{
\FQRNj?'_
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ l%k\JY-
`x+ B+)0X
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ ,k +IPkN+
[\^n=
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ fx41,0;gZq
"%`1]Fr
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? >:74%D0UF
Ci@o|Y }tP
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ z`.<U{5
>{q]&}^U
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ "Gsc;X'id
5Yg'BkEr
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ %f&/E"M
7x"R3
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ nHM~
LA!?H]
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© VACQ+
Vh'P&W?[
1. immunoglobulin gene rearrangement aB_F9;IR
ef8s<5"4
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) "M<8UE \n
\ ZgE
3. flow cytometry(FCM) Gt\lFQ
1h^:[[!c
4. carrier effect 0pZ4BZd
T|
=mO vs
5. positive selection of T lymphocytes in thymus bg!/%[ {M
hCi 60%g/n
6. mouse TH1(Th1) and TH2(Th2) subsets prWk2_D;*
{kA0z2Fe
7. perforin (pore-forming protein ,PFP) /MIe(,>Uh
qLO4#CKCL6
8. ADCC(antibody-dependent cell-mediated cytotoxicity) 5VfyU8)7X
EuEZ D+
9. SH-2(src-homology region 2) ~Q Oe##
/fKx}}g)
10. Ab2¦Â (internal image) 0CWvYC%e
`XJG(Oas\
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© MR;1
2*p
TEP,Dq
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? 3$jT*OyG#
+vw\y
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? Z&G+bdA>,
Yz'K]M_Dq
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ8Q.T g.
$By<$
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ M-$%Rzl_
^6jV_QM#
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠIDad9 Bx
vt/x
,Y
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) C1V|0hu
Ja|5 @
ÃâÒßѧרҵ£º Rm2yPuOU}A
b10cuy|a/X
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ '@a}H9>}
ZAW^/bo<
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ?
$r^GE
kC:uG0sW
´«È¾²¡Ñ§×¨Òµ£º C>]0YO
k2
55G+;
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ <KJ/<0l
gl~ecc
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ rbul8(1h
aJSO4W)P
Ïû»¯×¨Òµ£º 'HO$C,1]
KsddA
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ Mhm@R@
|+{)_?
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? M5i%jZk
mJ<=n?{Z
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ a f6M,{F
\0A3]l
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© se ba9y
?)/#+[xa
1. Fas(CD95)/FasL O8f?; ]
M
+-*QyCFK
2. common chain of cytokine receptor <3L5"77G6
)i6mzzj5
3 . TCR/CD3 complex )"qa kT
)tG\vk=@
4. negaive selection of thymocytes *=) cQeJ
} FE>|1
5. artificial active immune 2L!u1
$5>e
6. anti-idiotypic 1eA7>$w}[
j*d
yp
7. IgSF CMe
06^U
4"GR]
X
8. Integrin Ig
$(3p
\-L&5x"x
9. chemokine W=lyIb{?^0
@efh{
10. B7/CD28 Y=%tn8<
w?3p';C
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© zy?.u.4L
$yN{-T"
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ 'QJ:`)z
5]~'_V
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ s:?SF.
Y)1PB+
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ Ha(c'\T(\
j
>Ht @Wi
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ @#<D ^"
%}[i'rT>
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ Jlri*q"hE
oxC[F*mD
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ V n7*JS
\}+_Fo/
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© R(!s
t=rEt>n~L
1. B7/CD28 Olt`:;j-
t
4PK}>QW
2. Th1 subset .O74V~T
r/4``shg
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© wZG\>9~
ccNd'2P
4. antibody affinity maturation _?<|{O
^.1)};i
5. AP-1 0bz'&
KmMzH`t}`
6. single chain variable fragment£¨ScFv£© RdWRWxTn8+
u_hD}V^x4
7. NK cell receptor .GV;+8HzS
^2+yHw
8. Zinkernagel-Doherty phenomenon .+qQYDEw
RwKdxK+;
9. Ig fold
05z,b]>l
t'VV>;-RO=
10. CD40/CD40L !i{aMxUP
W6f/T3
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© H+1-] 'g`
9G9fDG#F\I
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ 6 2'j!"xv
->sm+H-*
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ 9zZr^{lUl
)+l\w3^6
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ [OM7g'?S0
\wo?47+=
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ 0>C T=(A
,#Iu
7di
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ yGWxpzmRS
cU;iUf
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ F=`AY^u0
C3eR)Yh
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ u6T+Cg
(}a8"]Z
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
vu|n<
lV`Q{bd+
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© #OIcLEn%
s8-<m,*
1.Co-stimulators (or co-stimulating molecules) KB%"bqB|
Ey_" ~OB
2.NK-kB /]=C{)8
)Gj8X}DM
3.Immunoglobulin superfamily bvS(@
qDv9
3
4.antigen-presenting cell (APC) 8)O[Aq::
=; ^%(%Y{m
5.death domain z8QAo\_I(
,
8:(OB|a
6.CCR and CXCR U'8bdsF_
Qj,]N@7
7.Lectin (or mitogen)
hCCiD9gz
p89wNSMl[
8.Clusters of differentiation, CD) WKT4D}{1
YQ39A_e
g
9.B7 family .
C&ktU4
*"D3E7AO
10.Cytotoxic T lymphocyte, CTL) 4G$|Rx[{,
^~G8?]w
11.IL-15 and IL-15 receptor (IL-15R) MP_'D+LS
F_;vO%}
12.MHC restriction zoOaVV&1
!OBEM1~
1
13.Affinity-chromatography !'mq ?C=
%;e/7`>Ma
14.Cyctosprin A, CsA >Y
#t`6,!
#tZ4N7
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) $4tWI O
BB~OqZIP
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© ]T;EdK-
*tgnYa[l
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 D+]a.& {p
TQx.KM>y
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ b!sRk@LGZ
4F
{)i
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ >S'17D
6`v7c!7
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© bzX\IrJpOZ
q~3,yyu
ÃâÒßѧרҵ£º E-I-0h
2
<5NF;
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ m|=H#
_io+YzS
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ q|Q k2M
=Qgt${|
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ H63,bNS s
\T<$9aNb
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) 0&/b42W
+"8,Mh
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) 91$]Qg,lB
:{oZ ~<
1. ADCC(antibody dependent cell-mediated cytotoxicity) rk7QZVE
n84GZ5O>7
2. »·æß¾úËØ(cyclosporin) U7I qST
<
V\I~;
3. KIR(killer cell inhibitory receptor) !zPa_`P
>2]JXLq
4. HLDA(human leucocyte differentiation antigen) # *TEq
s1e:v+B]
5. Interleukin 18(IL-18) nzmDA6d
2 Sh
6. ÕûºÏËØ(integrin) h}]fnA
7DIIx}A
7. Fas/FasL [+OnV&
v{9t]s>B
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) C&6IU8l\
}J7zTj~{
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) om]4BRe
r\blyWi
10. Th1/Th2 04*6(L)h*
S6fL>'uQ
11. »ùÒòÒßÃç(DNAÒßÃç) z^GDJddG
H6&J;yT}
12. chemokines and chemokine receptor \TF!S"V
3 q`)*
13. ÃâÒßÄÍÊÜ P1NJ^rX
4WE6fJ2X
14. ¹²´Ì¼¤·Ö×Ó Dc+'<"
r YF #^
15. ËÀÍö½á¹¹Óò(death domain) ?_ dIIQ
+Y
V|ij
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) m~dC3}e8/?
TARXx>
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? ]XTu+T.aT
;/0 Q1-
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠe#B#B
qVdwfT{1J
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î UK{irU|\
m
~>Y{F2
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ #BQ.R,
8kbY+W%n
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå {<5ybbhLV
Q0\0f
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ o=RM-tR`v
8v71e>
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) LPwT^zV&N
fl;s9:<
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ 0[F:'_
-!)xQvagD.
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ gt\MS;jMa
.@"q$\
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£